Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
genentech
5
×
life sciences
national blog main
national top stories
san francisco blog main
5
×
san francisco top stories
eli lilly
indiana blog main
indiana top stories
boulder/denver blog main
boulder/denver top stories
cancer
celgene
deals
detroit blog main
detroit top stories
investing
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agenus
avapritinib
blueprint medicines
boston
bristol-myers squibb
What
drug
5
×
bio
fda
roundup
approval
approved
blueprint
cancer
companies
latest
medicines
news
ret
address
adu
alzheimer’s
approves
beats
bids
biogen
candidate
carries
certain
complicated
currently
depression
designed
different
digital
dire
disease
epidemic
fail
fatty
frenzied
gene
genetic
good
group
growing
Language
unset
Current search:
genentech
×
drug
×
" san francisco blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More